Skip to main content
Equibles
CLDI logo

CLDI · Calidi Biotherapeutics, Inc.

Track CLDI — free

Use CLDI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.35 +0.03 (+1.89%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$3.41M
Shares
2.58M

Calidi Biotherapeutics, Inc. Earnings Call Transcripts

Quarterly earnings calls for Calidi Biotherapeutics, Inc. (CLDI), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Key facts CIK 1855485 CUSIP 320703408 13F (30d) 15 filings 15 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)